{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:06:40Z","timestamp":1773306400545,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jacl.2010.08.020","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T09:56:57Z","timestamp":1283335017000},"page":"515-521","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and tolerability of extended-release niacin\/laropiprant in dyslipidemic patients with metabolic syndrome"],"prefix":"10.1016","volume":"4","author":[{"given":"Harold E.","family":"Bays","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"McCrary Sisk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darbie","family":"Maccubbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2010.08.020_bib1","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2010.08.020_bib2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/diacare.25.3.627","article-title":"Fenofibrate lowers plasma triglycerides and increases LDL particle diameter in subjects with type 2 diabetes","volume":"25","author":"Vakkilainen","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2010.08.020_bib3","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","article-title":"Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacl.2010.08.020_bib4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1021\/jm0603668","article-title":"Discovery of a Potent and Selective Prostaglandin D(2) Receptor Antagonist, [(3R)-4-(4-Chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic Acid (MK-0524)","volume":"50","author":"Sturino","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.jacl.2010.08.020_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.amjcard.2007.10.023","article-title":"Effects of laropiprant on nicotinic acid-induced flushing in dyslipidemic patients","volume":"101","author":"Paolini","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2010.08.020_bib6","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1742-1241.2008.01938.x","article-title":"Lipid-modifying efficacy and tolerability of extended release niacin\/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia","volume":"62","author":"Maccubbin","year":"2008","journal-title":"Int J\u00a0Clin Pract"},{"key":"10.1016\/j.jacl.2010.08.020_bib7","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1016\/j.amjcard.2008.02.026","article-title":"Safety of niacin and simvastatin combination therapy","volume":"101","author":"Bays","year":"2008","journal-title":"Am J\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2010.08.020_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"NCEP Report. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2010.08.020_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1742-1241.2008.01934.x","article-title":"Does nicotinic acid (niacin) lower blood pressure?","volume":"63","author":"Bays","year":"2009","journal-title":"Int J Clin Pract"},{"issue":"suppl","key":"10.1016\/j.jacl.2010.08.020_bib10","doi-asserted-by":"crossref","first-page":"22C","DOI":"10.1016\/j.amjcard.2006.11.018","article-title":"Safety considerations with niacin therapy","volume":"99","author":"Guyton","year":"2007","journal-title":"Am J\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2010.08.020_bib11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-9149(97)01016-3","article-title":"Effects of crystalline nicotinic acid-induced hepatic dysfunction of serum low-density lipoprotein cholesterol and lecithin cholesteryl acyl transferase","volume":"81","author":"Tat\u00f2","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2010.08.020_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9343(92)90018-7","article-title":"Hepatic toxicity of unmodified and time-release preparations of niacin","volume":"92","author":"Rader","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2010.08.020_bib13","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archinte.162.14.1568","article-title":"Efficacy, safety, and tolerability of once-daily niacin for the treatment of dysplipidemia associated with type 2 diabetes\u2014results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial","volume":"162","author":"Grundy","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2010.08.020_bib14","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jama.284.10.1263","article-title":"Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease","volume":"284","author":"Elam","year":"2000","journal-title":"JAMA"},{"issue":"1 Suppl","key":"10.1016\/j.jacl.2010.08.020_bib15","first-page":"S26","article-title":"\u201cSick fat,\u201d metabolic disease, and atherosclerosis","volume":"122","author":"Bays","year":"2009","journal-title":"Am J\u00a0Med"},{"key":"10.1016\/j.jacl.2010.08.020_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.amjcard.2004.09.013","article-title":"Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project)","volume":"95","author":"Canner","year":"2005","journal-title":"Am J Cardiol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287410003168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287410003168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T12:27:10Z","timestamp":1544272030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287410003168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1933287410003168"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2010.08.020","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}